The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity
Open accessAbstract
CCR5, a chemokine receptor expressed on T cells and macrophages, is the principal coreceptor for M-tropic HIV-1 strains. Recently, we described an NH2-terminal modification of the CCR5 ligand regulated on activation, normal T cell expressed and secreted (RANTES), aminooxypentane-RANTES (AOP-RANTES), that showed potent inhibition of macrophage infection by HIV-1 under conditions where RANTES was barely effective. To investigate the mechanism of AOP-RANTES inhibition of HIV infectivity we examined the surface expression of CCR5 using a monoclonal anti-CCR5 antibody, MC-1. We demonstrate that AOP-RANTES rapidly caused >90% decrease in cell surface expression of CCR5 on lymphocytes, monocytes/ macrophages, and CCR5 transfected Chinese hamster ovary (CHO) cells. RANTES also caused a loss of cell surface CCR5, although its effect was less than with AOP-RANTES. Significantly, AOP-RANTES inhibited recycling of internalized CCR5 to the cell surface, whereas RANTES did not. When peripheral blood mononuclear cells are cultured for prolonged periods of time in the presence of RANTES, CCR5 expression is comparable to that seen on cells treated with control medium, whereas there is no CCR5 surface expression on cells cultured in the presence of AOP-RANTES. Immunofluorescence indicated that both AOP-RANTES and RANTES induced downmodulation of cell surface CCR5, and that the receptor was redistributed into endocytic organelles containing the transferrin receptor. When RANTES was removed, the internalized receptor was recycled to the cell surface; however, the receptor internalized in the presence of AOP-RANTES was retained in endosomes. Using human osteosarcoma (GHOST) 34/CCR5 cells, the potency of AOP-RANTES and RANTES to inhibit infection by the M-tropic HIV-1 strain, SF 162, correlated with the degree of downregulation of CCR5 induced by the two chemokines. These differences between AOP-RANTES and RANTES in their effect on receptor downregulation and recycling suggest a mechanism for the potent inhibition of HIV infection by AOP-RANTES. Moreover, these results support the notion that receptor internalization and inhibition of receptor recycling present new targets for therapeutic agents to prevent HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Expression cloning of new receptors used by simian and human immunodeficiency viruses
Deng, H., Unutmaz, D., KewalRamani, V. N., & Littman, D. R. (1997) · Nature · doi:10.1038/40894 · Cited by 684
CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81393-8 · Cited by 655
Self-citationPaxton, W. A., Martin, S. R., Tse, D., O'Brien, T. R., Skurnick, J., VanDevanter, N. L., Padian, N., Braun, J. F., Kotler, D. P., Wolinsky, S. M., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-412 · Cited by 648
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Self-citationAmara, A., Gall, S. L., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J.-L., & Arenzana-Seisdedos, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.139 · Cited by 552
Regulatory mechanisms that modulate signalling by G-protein-coupled receptors
BÖHM, S. K., GRADY, E. F., & BUNNETT, N. W. (1997) · Biochemical Journal · doi:10.1042/bj3220001 · Cited by 505
Moore, J. P., Trkola, A., & Dragic, T. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80110-0 · Cited by 495
Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E., & Wells, T. N. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2599 · Cited by 418
Self-citationSignoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., et al. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.651 · Cited by 375
Self-citationEndocytosis and recycling of G protein-coupled receptors
Koenig, J. A., & Edwardson, J. M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01091-2 · Cited by 357
Mack, M., Riethmüller, G., & Kufer, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7021 · Cited by 351 · cited 1×
“After subcloning into the PEF-DHFR vector, DHFR-deficient CHO cells were transfected by electroporation and selected for stable expression in nucleoside free MEM medium with 10% dialyzed FCS as described ( 19 ).”
MethodSelf-citationHIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Pleskoff, O., Tréboute, C., Brelot, A., Heveker, N., Seman, M., & Alizon, M. (1997) · Science · doi:10.1126/science.276.5320.1874 · Cited by 308
Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.405 · Cited by 289
HIV blocked by chemokine antagonist
Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., & Baggiolini, M. (1996) · Nature · doi:10.1038/383400a0 · Cited by 281
Aramori, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4606 · Cited by 248
Dual pathways of internalization of the cholecystokinin receptor.
Roettger, B. F., Rentsch, R. U., Pinon, D., Holicky, E., Hadac, E., Larkin, J. M., & Miller, L. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1029 · Cited by 232
Chemokines and HIV replication
Schmidtmayerova, H., Sherry, B., & Bukrinsky, M. (1996) · Nature · doi:10.1038/382767a0 · Cited by 178
RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors
Gong, J.-H., Uguccioni, M., Dewald, B., Baggiolini, M., & Clark‐Lewis, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10521 · Cited by 146
Alkhatib, G., Liao, F., Berger, E. A., Farber, J. M., & Peden, K. (1997) · Nature · doi:10.1038/40789 · Cited by 133
Endocytosis and recycling of G protein-coupled receptors
Koenig, J., & Edwardson, J. M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90643-x · Cited by 124
CD4-Independent Binding of SIV gp120 to Rhesus CCR5
Martin, K. A., Wyatt, R. T., Farzan, M., Choe, H., Marcon, L., Desjardins, E., Robinson, J. E., Sodroski, J., Gerard, C. J., & Gerard, N. P. (1997) · Science · doi:10.1126/science.278.5342.1470 · Cited by 107
Yang, A., Bai, X., Huang, X. F., Yao, C., & Chen, S. Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11567 · Cited by 106
Mutation of Leu25 and Val27 Introduces CC Chemokine Activity into Interleukin-8
Narasimhan, M., Power, C., Allet, B., Alouani, S., Bacon, K. B., Mermod, J., Proudfoot, A. E. I., & Wells, T. N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2716 · Cited by 80
Self-citationReceptor-mediated Endocytosis of CC-chemokines
Solari, R. C. E., Offord, R. E., Rémy, S., Aubry, J., Wells, T. N. C., Whitehorn, E. A., Oung, T., & Proudfoot, A. E. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9617 · Cited by 79
Self-citationRole of CD4 endocytosis in human immunodeficiency virus infection
Pelchen–Matthews, A., Clapham, P. R., & Marsh, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8164-8168.1995 · Cited by 66
Self-citationChemokine receptors — the new frontier for AIDS research
Wells, T. N. C., Proudfoot, A. E. I., Power, C. A., & Marsh, M. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90126-x · Cited by 55
Self-citationDual effect of CCR5 Δ32 gene deletion in HIV-1-infected patients
Garred, P., Eugen‐Olsen, J., Iversen, A. K. N., Bennfield, T. L., Svejgaard, A., & Hofmann, B. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63874-3 · Cited by 49
Mueller, S. G., Schraw, W. P., & Richmond, A. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10439 · Cited by 40
Cited by
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Synthesis of Native Proteins by Chemical Ligation
Dawson, P. E., & Kent, S. B. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.923 · Cited by 1,082
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Metadata
- Authors
- Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., Wells, T. N. C., Schlöndorff, D., & Proudfoot, A. E. I.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-04-20
- Volume
- 187
- Issue
- 8
- Pages
- 1215-1224
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154319486
- Cited by
- 405
- References
- 37
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.